Free tool
Stocks listed on Nasdaq GS
We cover 79 companies listed on Nasdaq GS. The median market value in the group is $3.98B. Across the group, the median move over the past trading day is −0.36%. 81% of the 74 with a 200-day average trade above it. Price change over the past year runs from −19.8% to +302.8% across the middle 80 percent of the group, with a median of +58.0%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
79 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| PODD | Insulet Corporation | $143.38 | −14.38% | −49.32% | −57.12% |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% |
| PCVX | Vaxcyte, Inc. | $61.09 | +11.89% | +31.49% | +99.97% |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% |
| BRKR | Bruker Corporation | $57.06 | −9.30% | +18.78% | +70.56% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| ALKS | Alkermes plc | $49.16 | −2.65% | +73.96% | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $93.61 | −6.36% | +206.10% | +446.12% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% |
| ERAS | Erasca, Inc. | $19.15 | +5.45% | +433.43% | +1112.03% |
| COGT | Cogent Biosciences, Inc. | $36.72 | −9.71% | +5.70% | +196.85% |
| AMRX | Amneal Pharmaceuticals, Inc. | $17.99 | −4.10% | +42.10% | +92.20% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $72.69 | −3.58% | −5.28% | +46.02% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $78.68 | −0.96% | +87.31% | +133.47% |
| DFTX | Definium Therapeutics, Inc. | $43.77 | +4.31% | +220.89% | +344.37% |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% |
| GRFS | Grifols, S.A. | $7.90 | −1.25% | −14.50% | −19.39% |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% |
| EWTX | Edgewise Therapeutics, Inc. | $44.38 | +9.99% | +86.86% | +207.13% |
| LFST | LifeStance Health Group, Inc. | $12.15 | +8.10% | +74.57% | +121.31% |
| WAY | Waystar Holding Corp. | $24.17 | +2.03% | −22.95% | −34.97% |
| BLLN | BillionToOne, Inc. | $96.22 | −28.00% | +7.76% | −11.68% |
| ICUI | ICU Medical, Inc. | $179.59 | +8.33% | +29.64% | +41.83% |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% |
| LIVN | LivaNova PLC | $79.97 | −2.58% | +31.88% | +41.56% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| INDV | Indivior Pharmaceuticals, Inc. | $35.83 | −12.60% | +0.27% | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% |
| IRTC | iRhythm Holdings, Inc. | $119.15 | +1.52% | −32.00% | −29.83% |
| LEGN | Legend Biotech Corporation | $20.68 | +8.61% | −3.86% | −40.44% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| DNLI | Denali Therapeutics Inc. | $24.57 | +2.16% | +51.01% | +57.50% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| TLX | Telix Pharmaceuticals Limited | $11.13 | +9.22% | +46.06% | −8.02% |
| OPCH | Option Care Health, Inc. | $24.04 | +6.94% | −25.43% | −15.91% |
| GRAL | GRAIL, Inc. | $79.59 | +23.55% | −10.44% | +136.66% |
| QURE | uniQure N.V. | $50.95 | +38.98% | +117.83% | +223.49% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% |
| MBX | MBX Biosciences, Inc. | $66.76 | +11.16% | +118.53% | +366.53% |
| BEAM | Beam Therapeutics Inc. | $30.19 | +14.83% | +11.24% | +79.06% |
| ARQT | Arcutis Biotherapeutics, Inc. | $25.14 | −11.54% | −13.31% | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $70.65 | +19.85% | −12.53% | +22.19% |
| ALMS | Alumis Inc. | $23.62 | −12.62% | +163.76% | +380.08% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ALHC | Alignment Healthcare, Inc. | $13.90 | −24.58% | −31.26% | −13.88% |
| ACHC | Acadia Healthcare Company, Inc. | $30.58 | −6.45% | +114.00% | +37.81% |
| PRVA | Privia Health Group, Inc. | $21.07 | −15.14% | −10.19% | −3.13% |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% |
| RARE | Ultragenyx Pharmaceutical Inc. | $26.44 | +1.77% | +12.03% | −12.10% |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $9.83 | +0.92% | +31.07% | +15.38% |
| KLRA | Kailera Therapeutics, Inc. | $18.44 | +10.16% | −29.08% | −29.08% |
| ALMR | Alamar Biosciences, Inc. | $34.08 | +37.92% | +54.91% | +54.91% |
| COAG | Hemab Therapeutics Holdings, Inc. | $49.19 | +4.08% | +44.68% | +44.68% |
| MLYS | Mineralys Therapeutics, Inc. | $25.89 | −3.93% | −27.50% | +70.22% |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% |
| CLOV | Clover Health Investments, Corp. | $4.25 | −1.96% | +76.35% | +57.99% |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% |
| XRAY | DENTSPLY SIRONA Inc. | $10.93 | −18.98% | −3.02% | −21.61% |
| ZBIO | Zenas BioPharma, Inc. | $33.04 | +2.32% | −4.23% | +97.73% |
| HCM | HUTCHMED (China) Limited | $12.35 | +10.27% | −9.52% | −17.45% |
| STOK | Stoke Therapeutics, Inc. | $33.09 | +12.59% | +7.09% | +71.45% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| NVCR | NovoCure Limited | $17.89 | +9.69% | +36.36% | +50.21% |
| GENB | Generate Biomedicines, Inc. | $16.14 | +22.83% | +27.59% | +27.59% |
| SRPT | Sarepta Therapeutics, Inc. | $19.46 | +26.12% | −8.68% | +7.69% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.99 | −5.56% | +25.06% | −13.45% |
| CMPS | COMPASS Pathways plc | $14.61 | +34.65% | +123.05% | +209.53% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.